Once-a-Day Ceftriaxone–Amikacin Combination as Empiric Antibiotic Therapy to Enable Outpatient Management of Febrile Neutropenia in Children—16-Year Experience from a Single Institute

Once-a-Day Ceftriaxone–Amikacin Combination as Empiric Antibiotic Therapy to Enable Outpatient Management of Febrile Neutropenia in Children—16-Year Experience from a Single Institute

Abstract Shailesh Kanvinde Background To enable outpatient department (OPD) management of febrile neutropenia (FN), we used once-a-day (OD) ceftriaxone–amikacin (CFT-AMK) as empiric antibiotic therapy...

Full description

Bibliographic Details
Main Authors:	Shailesh Kanvinde, Atul Mulay, Anand Deshpande, Chetan Deshmukh, Sampada Patwardhan
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-10-01
Series:	South Asian Journal of Cancer
Subjects:	febrile neutropenia outpatient management ceftriaxone–amikacin
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1745834

Similar Items

Efficacy and toxicity of once versus twice daily regimens of amikacin in febrile neutropenic pediatric cancer patients
by: Reda Abd-Elfattah, et al.
Published: (2017-03-01)

Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma
by: Antonio Sérgio Petrilli, et al.

Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma
by: Petrilli Antonio Sérgio, et al.
Published: (2003-01-01)

How I treat febrile neutropenia
by: Marcio Nucci
Published: (2021-02-01)

Optimizing Empiric Vancomycin Use in Febrile Neutropenia Patients
by: Nicole Tadros, et al.
Published: (2021-12-01)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
by: Doaa Naeem, et al.
Published: (2018-08-01)

Prevention of febrile neutropenia in oncological patients: real-world data
by: Kirill V. Sapozhnikov, et al.
Published: (2023-05-01)

Febrile Neutropenia Due To Brucellosis: Case Report
by: Abdullah Sakin, et al.
Published: (2012-06-01)

Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases
by: Sang Ngoc Nguyen, et al.
Published: (2022-08-01)

Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy
by: Maria Bachlitzanaki, et al.
Published: (2023-10-01)

Febrile Neutropenia in Intensive Care Unit
by: Nattamol Hosiriluck, et al.
Published: (2015-07-01)

Validation of the CSRFENCE score for prediction of febrile neutropenia during chemotherapy cycles 2–6
by: Razan Zatarah, et al.
Published: (2022-10-01)

Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
by: Müge ASLAN, et al.
Published: (2014-12-01)

The cost effectiveness of the respiratory virus panel in childhood febrile neutropenia
by: Hüsamettin Vatansev, et al.
Published: (2023-03-01)

Ceftriaxone-induced Agranulocytosis
by: Lénio Couto, et al.
Published: (2021-01-01)

Febrile neutropenia in the emergency department
by: Malle Simeon, et al.
Published: (2021-01-01)

Optimising Antimicrobial Selection and Duration in the Treatment of Febrile Neutropenia in Children
by: Morgan JE, et al.
Published: (2021-03-01)

The risk factors for febrile neutropenia during chemotherapy in children with malignancy
by: Rini Sulviani, et al.
Published: (2007-05-01)

Febrile neutropenia in childhood leukemia: Manado experience 1997 - 2006
by: Stefanus Gunawan, et al.
Published: (2009-12-01)

Secondary Infections in Cancer Patients with Febrile Neutropenia
by: Alpay Azap, et al.
Published: (2012-08-01)

Caracterización de los pacientes que ingresan a UCIP por neutropenia febril Clínica Prevenir Barranquilla 2015 –2016
by: Malvin Medina Caicedo
Published: (2017-12-01)

Chemotherapy Induced Neutropenia, Febrile-Neutropenia and Determinants Among Solid Cancer Patients Attending Oncology Unit of a Tertiary Care Teaching Hospital in Ethiopia
by: Dessalegn M, et al.
Published: (2023-02-01)

Prevalencia de gérmenes con multirresistencia antibiótica en bacteriemia asociada a neutropenia febril en pacientes oncológicos hospitalizados
by: Carlos Soliz Poveda, et al.
Published: (2022-08-01)

Clozapine-Induced Febrile Neutropenia and Cellulitis
by: Selcuk YAYLACI, et al.
Published: (2014-03-01)

Doente com Neutropenia Febril: Uma Intervenção Especializada – Revisão Integrativa da Literatura
by: Cristina Santos, et al.
Published: (2021-06-01)

Febrile neutropenia management in pediatric onco-hematologic patients: a systematic review
by: Tatiane Bertella, et al.
Published: (2021-10-01)

Neutropenia febril: convertir el bajo riesgo en cero riesgo To convert the low risk in zero risk in patients with febrile neutropenia
by: Alberto Arencibia Núñez
Published: (2009-08-01)

Etiología bacteriana y susceptibilidad antibiótica en adultos con leucemias agudas y neutropenia febril con factores de alto riesgo
by: Jonathan Darío Ortega Calderón, et al.
Published: (2021-04-01)

Comparison of the Efficacy of Beta-Lactam Monotherapy and Beta-Lactam and Amikacin Combination Therapy for the Empirical Treatment of Febrile Neutropenic Patients
by: Mustafa DOĞAN, et al.
Published: (2009-03-01)

Re-thinking treatment strategies for febrile neutropenia in paediatric oncology population: the perspective from a developing country
by: Vinson James, et al.
Published: (2021-06-01)

Analyse of Febrile Neutropenia Attacks in Children with Acute Lymphoblastic Leukemia
by: Meriban Karadoğan, et al.
Published: (2023-09-01)

Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia
by: Keegan Peter Janssens, et al.
Published: (2021-05-01)

Standart and Lipozomal Amphotericin B in Febrile Neutropenia with Hematological Malignancies
by: H. Şenol COŞKUN, et al.
Published: (1998-06-01)

EVALUATION OF ANTIBIOTIC IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WITH FEBRILE NEUTROPENIA
by: Ambar Yunita Nugraheni, et al.
Published: (2020-04-01)

Effect of an education program on knowledge, self-care behavior and handwashing competence on prevention of febrile neutropenia among breast cancer patients receiving Doxorubicin and Cyclophosphamide in Chemotherapy Day Centre
by: Wai Chi Mak, et al.
Published: (2015-01-01)

PERFIL DE PACIENTES HEMATOLÓGICOS COM NEUTROPENIA FEBRIL: ESTUDO OBSERVACIONAL
by: Raphael Braz de Carvalho, et al.
Published: (2023-08-01)

The effect of leptin gene polymorphisms (LEP rs7799039 and LEPR rs1137101) on febrile neutropenia
by: Ezgi Paslı Uysalol, et al.
Published: (2024-04-01)

Management of febrile neutropenia: A description of clinical and microbiological findings by focusing on risk factors and pitfalls
by: Fatemeh Karimi, et al.
Published: (2018-01-01)

La neutropenia severa febril en niños con cáncer: Estudio descriptivo en el Hospital Universitario de Santander Severe febrile neutropenia in children with cancer: A descriptive study at the Hospital Universitario de Santander
by: Ernesto Rueda, et al.
Published: (2010-08-01)

The Organisms Isolated During Febrile Neutropenic Episodes
by: Kürşat KAPTAN, et al.
Published: (1999-03-01)